Application Type
Patent
Application SubType
PCT National Phase
(10) Registration Number and Date
BNN20200096 30.08.2021
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
BN N/2020/0096 07.05.2019
(40) Publication Number and Date
BN N/2020/0096
A
30.08.2021
(86) PCT Filing Number and Date
(87) PCT Publication Number and Date
(85) National Entry Date
(30) Priority Details
US 62/668,321
08.05.2018
US 62/754,814
02.11.2018
(51) IPC Classes
(72) Inventor
(EN) BAGAL, Sharanjeet, Kaur : 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge Cambridgeshire, CB2 0AA
(EN) FILLERY, Shaun, Michael : 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge Cambridgeshire, CB2 0AA
(EN) ROBB, Graeme, Richard : 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge Cambridgeshire, CB2 0AA
(EN) LAMONT, Scott, Gibson : 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge Cambridgeshire, CB2 0AA
(EN) KEMMITT, Paul, David : 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge Cambridgeshire, CB2 0AA
(74) Representative Name
(EN) AIP Law : Unit Nos. 404A-410A, 4th Floor, Wisma Jaya, Jalan Pemancha, Bandar Seri Begawan BS8811, Brunei Darussalam
(54) Title
(EN) TETRACYCLIC HETEROARYL COMPOUNDS
(57) Abstract
(EN)

The specification relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof. The specification also relates to processes and intermediates used for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.

(58) Citations
Document Type Date Action
Event NameDateStatus
Filing07.05.2019Filed
PCT National Phase Entry07.11.2020PCT National Phase
Registration30.08.2021Registered
Publication30.08.2021Published